chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm soreness , 103.7 fever , Chills body ache , nausea , muscle pain on legs and feet . Headache ,  fatigue and  persistent rash   Still have rashes since administered 2ns shot .  I break out on hives constantly .  Specially after going tour side in the heat .   I get hives at home when I get hot .  My hives are raised and painful .  I can?t go outside without getting hives .  If I drink milk I have hives as well.
Chills and Body Aches began the following morning after the injection and by 2:00 pm in the afternoon a large (ping pong ball sized) lump developed in the left axillary area that is very painful. The pain is constant when area is touched or with any arm movement. It feels like a knife is stuck inside my left axilla. I am guessing it may be a lymph node that swelled, but have not had it checked by a doctor. My last mammogram  on November 16th, 2020 was clear and no indication of any lumps or swollen lymph nodes. This new lump appeared the following day after my Covid 19 vaccine.
Covid-19/ developed foul taste; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19/ developed foul taste) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19/ developed foul taste). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) on 23-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19/ developed foul taste) outcome was unknown.            No concomitant drug information was provided. It was reported that patient had developed foul taste after taking Paxlovid which subsided overnight but upon taking next dose at 7:30, foul taste resumed and was more worse than the previous day. It was also reported that the patient experienced low grade temperatures (nothing over 100) body aches, coughing, headache and congestion. Patient had Moderna shots and both boosters.  No treatment drug information was provided.  Company comment: This is a spontaneous case concerning a 72-year-old, female patient with no reported medical history and with vaccine history of receiving mRNA-1273, who experienced the unexpected non-serious AESI event of Covid-19. The event occurred after the unknown dose number of mRNA-1273 vaccine administration. Allegedly the event was described as, patient experienced low grade temperatures, body aches, coughing, headache and congestion. Patient took Paxlovid (Nirmatrelvir + Ritonavir) and developed foul taste. No other information surrounding the event was reported. The outcome of the event was unknown. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 72-year-old, female patient with no reported medical history and with vaccine history of receiving mRNA-1273, who experienced the unexpected non-serious AESI event of Covid-19. The event occurred after the unknown dose number of mRNA-1273 vaccine administration. Allegedly the event was described as, patient experienced low grade temperatures, body aches, coughing, headache and congestion. Patient took Paxlovid (Nirmatrelvir + Ritonavir) and developed foul taste. No other information surrounding the event was reported. The outcome of the event was unknown. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Initial information received on 24-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves an unknown age female patient who felt burning or warmth in her skin at the chest or upper torso area around the shoulder and neck, while she received vaccine FLUZONE QUADRIVALENT. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. On unknown date, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UJ025AC via unknown route in the arm NOS. The patient was treated with BENADRYL ITCH. The patient experienced a non-serious felt burning or warmth in her skin at the chest or upper torso area around the shoulder and neck (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Other relevant tests included no lab data. Final diagnosis was felt burning or warmth in her skin at the chest or upper torso area around the shoulder and neck. The patient outcome was not reported. List of documents held by sender: none.
joint pain that is lingering 3+ weeks. The first week was really bad pain all over my body. Now it is in my hands, fingers, wrists, feet and toes.
This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 17-SEP-2015, the patient was vaccinated with an improperly stored dose of MMR II (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
STIFFNESS IN NECK; DULL ACHE IN NECK; FOCUS ISSUE; BODY ACHE; FEVER; FATIGUE/EXHAUSTION; INTERMITTENT HEADACHE; This spontaneous report received from a consumer concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included hydrocodone allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported. On 26-MAR-2021, the subject experienced stiffness in neck. On 26-MAR-2021, the subject experienced dull ache in neck. On 26-MAR-2021, the subject experienced focus issue. On 26-MAR-2021, the subject experienced body ache. On 26-MAR-2021, the subject experienced fever. On 26-MAR-2021, the subject experienced fatigue/exhaustion. On 26-MAR-2021, the subject experienced intermittent headache. Laboratory data included: Body temperature (NR: not provided) 101. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and fever on 27-MAR-2021, and had not recovered from fatigue/exhaustion, intermittent headache, dull ache in neck, stiffness in neck, and focus issue. This report was non-serious.
Patient had immediate rash and itchyness, erythema at the injection site and this has changed, some rashes coming and going, now >4 weeks out still with inflammatory reaction and itchyness distal to injection site.
Grew increasingly tired as the day wore on. Took 2-3 naps during the day before going to bed for the night. On second day after the shot, was fine.
Phone call from foster mother reporting that child had quarter size area of redness and swelling at 6:30 on 03/19/2019. Stated this are grew to golf ball size area of redness and swelling on 03/20/2019 and on 03/21/2019, it had grown to softball size area of redness, swelling that is hot to touch. Has used warm moist compresses with no relief.
10/24/02 Evening throat sore, sleepy (9PM), temperature 99.2. 10/25/02 Up once at night; 6AM nauseated, temperature 99.9. No emesis, slight headache, slept most of day. 4PM warm, sleepy.
PATIENT TESTED POSITIVE TO COVID-19 ON 8/24/21. PATIENT HAD RECEIVED PFIZER COVID-19 VACCINE AS FOLLOWS, Dose 1 date: 12/29/20 and Dose 2 date: 1/19/21.
Arm really sore; General aches and pains; Chills; Tired; Its put on my ass; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm really sore), MYALGIA (General aches and pains), CHILLS (Chills), FATIGUE (Tired) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Its put on my ass) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Pfizer Comirnaty (Dose 1), Pfizer Comirnaty (Dose 3) and Pfizer Comirnaty (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer Comirnaty, Pfizer Comirnaty and Pfizer Comirnaty.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm really sore), MYALGIA (General aches and pains), CHILLS (Chills), FATIGUE (Tired) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Its put on my ass). At the time of the report, PAIN IN EXTREMITY (Arm really sore), MYALGIA (General aches and pains), CHILLS (Chills), FATIGUE (Tired) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Its put on my ass) outcome was unknown.            No concomitant medication provided. No treatment information mentioned.  Patient took 3 doses of Comirnaty and felt fine. Took one dose of Moderna COVID vaccine, was put on his behind, and arm was really sore, chills, tired and general aches and pains.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
severe allergic reactions; Severe allergic reactions of hives; Breakout of rash; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 60-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in February 2019).   In May 2019, the patient received the 2nd dose of Shingrix. In October 2019, less than 6 months after receiving Shingrix, the patient experienced allergic reaction, hives and vesicular rash. On an unknown date, the outcome of the allergic reaction, hives and vesicular rash were unknown.   It was unknown if the reporter considered the allergic reaction, hives and vesicular rash to be related to Shingrix.  Additional details were provided as follows: The patient age was 59 years old at the time of vaccination. The patient received dose of Shingrix in May 2019 and experienced breakout of rash and hives since from October 2019. Till the time of reporting, the patient had 3rd occurence of breakout of rash and hives.
pt vax'd /w 1st dose of hepatitis B and later developed flu-like syn,malaise,fatigue,& fever.after 2nd dose pt developed same sx but only more severe;
The vaccine should have been discarded at 2:07pm since was put at room temp at 8:07am but this vaccine was given at 6pm. She has no issues as a result but we are having her come back in to repeat the dose.
I could breathe like I have not able to breathe in years; This is a spontaneous report received from Pfizer. A contactable consumer, the patient, reported a patient of unspecified age/gender received the first dose BNT162b2 (solution for injection; batch/lot and expiry information not reported) as a single dose via unspecified route on 15Mar2021, for COVID-19 immunisation. Relevant medical history included ongoing Chronic Obstructive Pulmonary Disease (COPD). There were no concomitant medications reported. The patient reported that he/she received the first dose of the vaccine last Monday (15Mar2021) and Tuesday and Wednesday he/she could breath like they have not been able to in years. The patient reported that he/she has COPD and unfortunately it was only a two-day good breathing event. The patient explained that he/she has asked around and several people that have COPD have said the same thing and for them it was also was short-lived. The outcome of the event breathe like I have not able to breathe in years was recovered on 18Mar2021.  No follow-up attempts possible; No further information expected and information about batch /lot number(s) cannot be obtained.
I thought I was having a heart attack. I went to the hospital. And was experiencing adverse symptoms, as defined by the hospital record. Myoconditus
Injection was in left arm and left armpit is very sore, painful, swollen and tender. Injection site is also red and swollen.
Within 15 - to 20 minutes, generalized urticaria and wheezing. Treated with Epinephrine 0.2ml of 1:100U and 50mg Benadryl IM.
Initially itching of arms and scalp then later cold sores on or about 10-15-2018. Then long resolution of some sores but then new ones appeared (vesicular). MD contacted 11/15/2018. A prescription on Acyclovir was started on 11/15/18.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose04/06/21 2nd dose04/26/21 Diagnosed covid positive:09/12/21 Symptom onset:09/07/21 Exposure:Travel Symptoms:cough loss of smell/taste
Pain at the injection site; Fever/high the fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site) and PYREXIA (Fever/high the fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain at the injection site) and PYREXIA (Fever/high the fever). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site) and PYREXIA (Fever/high the fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2022, Body temperature: 98.5f (normal) normal temperature of around 98.5F.         Patient reported that more the severe pain at the injection site the high the fever patient had. On 05-Jan-2022, in the morning patient woke up with almost no pain and a normal body temperature of around 98.5 F.  No concomitant use were reported.  No treatment were reported.  Vaccine Information statement version date given is 19-Nov-2021.
Sore, red, itchy, SOB - 6/10 - still red, raised, warm to touch, itchy.
"COVID-arm" - red circle around injection site that was mildly itchy. Resolved within 2 weeks post vaccination.
pt recvd vax & exp flu-like symptoms & "severe" gastrointestinal symptoms;
28 year-old-male with no past medical history presented with episode of vasovagal syncope. Patient states he feels "dizzy, blurry vision, and lightheaded"  immediately after receiving the vaccination. The patient was placed on the floor by the nurse who administered the vaccine and his lower extremities were elevated. Patients HR was 68 and SpO2 was 98%. That patient was given fluids and then taken to the medical tent for evaluation. Vital signs were: BP 122/84, HR69, RR18, SpO2 98%, and Temp 98F.  After 5 minutes in the medical tent, the patient stated he felt much better and wanted to go home.
Patient was given her first dose of Moderna at a drive through clinic and instructed to wait the 15 minutes for observation.  During this time patient and her mother notified the staff member that patient was not feeling including feeling dizzy and nauseated and feeling abdominal discomfort with numbness and tingling of her tongue and lips.  RN  assessed patient and took vitals. Patient was alert and oriented and able to speak in full sentences,  denied SOB, chest pain and was breathing comfortably.  BP was 80/40 HR 50's, RR 18. The PA at the clinic where the clinic was being held assessed patient and assessed lung sounds which were clear and the patient then reported feeling "a lot better".  Color returned to her lips and face.  Patient was asked to stay on-site for continued observation before leaving. Approximately 10 minutes later patient asked to use the bathroom in our clinic.  She was advised she could go as long as her Mom was allowed to go in with her in case she experienced dizziness or needed help.   After 5-10 minutes the patient was still in the bathroom. RN who worked inside clinic checked on patient who reported diarrhea more dizziness and weakness.  After discussion with the provider it was  and patient's mother it was decided that the mother would drive the patient to the nearest emergency room although this patient is a (Name) patient, for further and continued assessment.  At this time the patient was speaking in full sentences able to walk and and did not report any breathing problems.  After helping patient back to her vehicle RN called ER to give report to the charge nurse.
bilat hip & lower leg pain 2 days p/vax;no sensory damage;exp gradual resolution;
Information has been received from a nurse practitioner concerning a 27 year old female with allergy to thimerosal and no medical history who on an unknown date, was vaccinated with GARDASIL (lot # not reported). There was no concomitant medication. "About three weeks ago" (on approximately 9-MAR-2009), the patient developed swollen and slightly red eyelids. An allergy skin test was performed (result unknown). The patient's swollen and slightly red eyelids persisted. The patient sought medical attention by office visit. Additional information has been requested.
blood clots from the moderna; Interchange of vaccine products; Revaccination with different COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clots from the moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (blood clots from the moderna) (seriousness criterion medically significant), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). At the time of the report, THROMBOSIS (blood clots from the moderna), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. Treatment medication was not provided by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Company comment-This is a spontaneous case concerning a patient of an unknown age and gender with no medical history reported, who experienced unexpected serious (medically significant) AESI of Thrombosis in the context of a dose of mRNA-1273 vaccine. Latency cannot be assessed since vaccination date nor event onset date were provided. No further information on detailed clinical course, investigations, treatment of the events was available in the report.  Outcome of the events was unknown at the time of report. Patient had received a dose of Pfizer COVID-19 vaccine on unknown date (Interchange of vaccine products). The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per medical judgement.; Sender's Comments: This is a spontaneous case concerning a patient of an unknown age and gender with no medical history reported, who experienced unexpected serious (medically significant) AESI of Thrombosis In the context of a dose of mRNA-1273 vaccine. Latency cannot be assessed since vaccination date nor event onset date were provided. No further information on detailed clinical course, investigations, treatment of the events was available in the report.  Outcome of the events was unknown at the time of report. Patient had received a dose of Pfizer COVID-19 vaccine on unknown date (Interchange of vaccine products). The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per medical judgement.
Facial paralysis; Migraines; pressure in my head and behind my eyes; pressure in my head and behind my eyes; chest pain; facial twitching and body twitching; dizziness; feeling of suffocation; left head, face, arm, hand, leg and foot paralysis; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER COVID-19) via an unspecified route of administration on the right arm on 08Apr2021 (Lot Number: ER8729) at the age of 45-year-old as single does for COVID-19 immunization. Medical history included COVID and thyroid. Known allergy was none. On 04May2021, the patient performed for COVID test (Nasal Swab) and result was negative. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient didn't receive other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included levothyroxine. The patient previously received the first dose of BNT162B2 via an unspecified route of administration on the right arm on 18Mar2021 (Lot Number: EN6208) at the age of 45-year-old as single does for COVID-19 immunization. On 04May2021 at 11:30 AM, the patient experienced facial paralysis, migraines, left head, face, arm, hand, leg and foot paralysis. The patient had since been back to withheld Hospital 2 times with facial paralysis, pressure in head and behind eyes, chest pain, facial twitching and body twitching. Waiting for next MRI and MRV, as patient have the feeling of suffocation and dizziness all the time and chest pain was completely fine before receiving the shot. The events resulted in hospitalization for 2 days. Treatment was received for events included CT Scan, MRI, EKG, IV Therapy. The outcome of events was not recovered.
Experiencing side effects 4 days after the first dose; low grade fever; Chills; headache; Side effects make her tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Experiencing side effects 4 days after the first dose), PYREXIA (low grade fever), CHILLS (Chills), HEADACHE (headache) and FATIGUE (Side effects make her tired) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0582EZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Sep-2021, the patient experienced VACCINATION COMPLICATION (Experiencing side effects 4 days after the first dose), PYREXIA (low grade fever), CHILLS (Chills), HEADACHE (headache) and FATIGUE (Side effects make her tired). At the time of the report, VACCINATION COMPLICATION (Experiencing side effects 4 days after the first dose), PYREXIA (low grade fever), CHILLS (Chills), HEADACHE (headache) and FATIGUE (Side effects make her tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: Follow-up information received  included new event (Vaccination complication).